Thought might be time to share a little research on Anteobind and how it is being utilised by others around the world with very good success.
The progress has taken a long time to be commercially recognized (I have been following it for near on a decade) but the last 12-24 months has seen many more research papers written and published by external companies, research institutes and labs utilising Anteobind to make life easier, faster and tests possible in labs around the world.
Here are a few examples of a few recently published papers using Anteobind for a wide range of uses.
1. Feb 2020 Study into porcupine reproductive and respiratory virus using anteobind for activation of surface
It definitely appears Anteobinds surface modification properties are being recognized much more broadly, there were very few papers published prior to 2020 using Anteobind as a surface modifier. Now all the above in last 18-24 months and it is growing rather quickly with more added so far this year then in the last decade.
Now revenue for selling lab study materials and quantities of Anteobind is negligible..... but its a foot into the doors of the lab and some of these studies using Anteobind will lead to future products like what has been seen with Ellume.
One Ellume contract may not turn this into a multi billion dollar business but more ongoing supply contracts will certainly help the cause going forward. Hence more exposure and labs, scientists, organizations using Anteobind the more follow through will happen in this part of the business.
It also shows the very broad market for future tests that can be targeted in house using Eugeni platform from viral to bacterial infections, to veterinary uses and tests to brain and heart ailments and also food safety testing all of it is possible and plausible.
Todays announcement will be a major turning point for the company as a whole, the board have moved and have done what was needed....the time had arrived.
If they can find the right new management structure (it appears life science is well covered for now with Chris, Ian, Pierre and Charlie) and replicate this with battery divisions and manufacturing divisions along with seeking to put in the right people at the top with the drive & ambition to build a global & diverse multibillion dollar company but also the skills and knowledge to back it up it will be a monumental turning point.
The tech is finally being recognized as world leading and the company have the two lead scientists spreading the message loud and clear with Charlie presenting this week on Friday as an expert speaker in Madrid on behalf of Merck, while Manuel takes the exceptional battery anode results to the world battery stage in Orlando next week.
The science teams are kicking major goals its time for the company to engage commercialization experts and negotiators, along with inspiring leadership to take the scientists hard work to the next level.
Never been a better time to be an Anteo holder in my opinion then right now, after confirmation of new management today its back to buy for me.
(might one day share some of my findings and research on batteries that is super exciting)
GLTA.
ADO Price at posting:
10.5¢ Sentiment: Buy Disclosure: Held
(20min delay)
